Published in

American Association for the Advancement of Science, Science Advances, 3(7), 2021

DOI: 10.1126/sciadv.abc4897

Links

Tools

Export citation

Search in Google Scholar

Multiple screening approaches reveal HDAC6 as a novel regulator of glycolytic metabolism in triple-negative breast cancer

Journal article published in 2021 by Catríona M. Dowling ORCID, Kate E. R. Hollinshead, Alessandra Di Grande, Justin Pritchard, Hua Zhang, Eugene T. Dillon, Kathryn Haley ORCID, Eleni Papadopoulos ORCID, Anita K. Mehta ORCID, Rachel Bleach ORCID, Andreas U. Lindner ORCID, Brian Mooney, Heiko Düssmann ORCID, Darran O’Connor ORCID, Jochen H. M. Prehn and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

Discovery of a new HDAC6 inhibitor reveals role for HDAC6 in the regulation of glycolytic metabolism.